483
Fresenius Kabi USA, LLCFresenius Kabi USA, LLC – FDA 483, Feb 4, 2016
Record Details
Fresenius Kabi USA, LLC, a sterile drug product manufacturer in Grand Island, NY, received an FDA Form 483 citing significant deficiencies. Observations included failures in the quality control unit's review of production records before batch release, inadequate investigation of unexplained discrepancies, and ineffective corrective actions for media fill contamination. Additionally, issues with employee training and the scientific justification for laboratory sampling plans were identified.
View Company Profile
ID · ac69efb9-d106-4581-b88d-dc3e158ca870
Other documents for Fresenius Kabi USA, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.